|Events|May 1, 2023
Compliance Congress for Specialty Products (9/19-9/21)
September 19-21, 2023 | Boston, MA
Reunite with Your Community to Overcome the Unique Risks & Challenges Associated with Complex Therapeutics
Bridge the gap between niche markets and industry standards to accelerate towards a solution catered exclusively for specialty pharmaceutical companies focuses on rare, ultra-rare and orphan diseases.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
Novo Nordisk Submits NDA to FDA for CagriSema
2
The End of the Rebate Era? What HR Leaders and Pharmacy Consultants Need to Know About Biosimilars
3
Roundup: Harbor BioMed Announces Collaboration and License Agreement with Bristol Myers, Squibb, VYNE Therapeutics Enters Merger Agreement with Yarrow Bioscience
4
Pfizer’s Stock Reacts to Decreases in 2026 Revenue Projections in Full-Year 2026 Guidance Release
5